Related references
Note: Only part of the references are listed.Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma
Yoshihiro Komohara et al.
CANCER SCIENCE (2011)
A System of Classifying Microvascular Invasion to Predict Outcome After Resection in Patients With Hepatocellular Carcinoma
Sasan Roayaie et al.
GASTROENTEROLOGY (2009)
Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time
Ivan Shabo et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Macrophage Markers in Serum and Tumor Have Prognostic Impact in American Joint Committee on Cancer Stage I/II Melanoma
Trine O. Jensen et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1
Dong-Ming Kuang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
G. Solinas et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Prognostic significance of macrophage infiltration in leiomyosarcomas
Cheng-Han Lee et al.
CLINICAL CANCER RESEARCH (2008)
Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival
Ivan Shabo et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma
Xiao-Dong Zhu et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas
Y. Komohara et al.
JOURNAL OF PATHOLOGY (2008)
Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma
Hui-Chuan Sun et al.
JOURNAL OF HEPATOLOGY (2007)
Soluble CD163 from activated macrophages predicts mortality in acute liver failure
Holger Jon Moller et al.
JOURNAL OF HEPATOLOGY (2007)
Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and evaluation of routine complete lymphadenectomy
Hui-Chuan Sun et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection
Qiang Gao et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
P48 is a predictive marker for outcome of postoperative interferon-α treatment in patients with hepatitis B virus infection-related hepatocellular carcinoma
Yong-Bing Qian et al.
CANCER (2006)
AM-3K, an anti-macrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype
Yoshihiro Komohara et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2006)
Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis
J Condeelis et al.
CELL (2006)
Distinct role of macrophages in different tumor microenvironments
CE Lewis et al.
CANCER RESEARCH (2006)
Analysis of multiple biomarkers, shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)
P Farinha et al.
BLOOD (2005)
Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage
TDT Nguyen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure
A Hiraoka et al.
JOURNAL OF GASTROENTEROLOGY (2005)
Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus
N Koide et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
CD163-A specific marker of macrophages in paraffin-embedded tissue samples
SK Lau et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2004)
CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response
SK Moestrup et al.
ANNALS OF MEDICINE (2004)
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
A Mantovani et al.
TRENDS IN IMMUNOLOGY (2002)
Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3
N Matsushita et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Development of an ELISA to measure soluble CD163 in biological fluids
TH Sulahian et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Identification of the haemoglobin scavenger receptor
M Kristiansen et al.
NATURE (2001)
Prognostic value of tumor-associated macrophage count in human bladder cancer
T Hanada et al.
INTERNATIONAL JOURNAL OF UROLOGY (2000)
Share Paper
